Atopy and Multisensitizations in Specific IgE Microarrays and Their Impact on Severe Asthma
Abstract
1. Introduction
2. Materials and Methods
3. Results
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Global Initiative for Asthma. Gina Main Report; Global Initiative for Asthma: Fontana, WI, USA, 2022. [Google Scholar]
- Hekking, P.-P.W.; Wener, R.R.; Amelink, M.; Zwinderman, A.H.; Bouvy, M.L.; Bel, E.H. The Prevalence of Severe Refractory Asthma. J. Allergy Clin. Immunol. 2015, 135, 896–902. [Google Scholar] [CrossRef] [PubMed]
- Marone, G.; Spadaro, G.; Braile, M.; Poto, R.; Criscuolo, G.; Pahima, H.; Loffredo, S.; Levi-Schaffer, F.; Varricchi, G. Tezepelumab: A Novel Biological Therapy for the Treatment of Severe Uncontrolled Asthma. Expert Opin. Investig. Drugs 2019, 28, 931–940. [Google Scholar] [CrossRef] [PubMed]
- Côté, A.; Godbout, K.; Boulet, L.-P. The Management of Severe Asthma in 2020. Biochem. Pharmacol. 2020, 179, 114112. [Google Scholar] [CrossRef]
- del Giacco, S.R.; Bakirtas, A.; Bel, E.; Custovic, A.; Diamant, Z.; Hamelmann, E.; Heffler, E.; Kalayci, Ö.; Saglani, S.; Sergejeva, S.; et al. Allergy in Severe Asthma. Allergy 2017, 72, 207–220. [Google Scholar] [CrossRef] [PubMed]
- Nelson, H.S. The Importance of Allergens in the Development of Asthma and the Persistence of Symptoms. J. Allergy Clin. Immunol. 2000, 105, 5–15. [Google Scholar] [CrossRef] [PubMed]
- Bozek, A.; Pyrkosz, K. Immunotherapy of Mold Allergy: A Review. Hum. Vaccin. Immunother 2017, 13, 2397–2401. [Google Scholar] [CrossRef] [PubMed]
- Mistry, H.; Ajsivinac Soberanis, H.M.; Kyyaly, M.A.; Azim, A.; Barber, C.; Knight, D.; Newell, C.; Haitchi, H.M.; Wilkinson, T.; Howarth, P.; et al. The Clinical Implications of Aspergillus Fumigatus Sensitization in Difficult-to-Treat Asthma Patients. J. Allergy Clin. Immunol. Pract. 2021, 9, 4254–4267. [Google Scholar] [CrossRef]
- Rossi, O.V.; Kinnula, V.L.; Tienari, J.; Huhti, E. Association of Severe Asthma Attacks with Weather, Pollen, and Air Pollutants. Thorax 1993, 48, 244. [Google Scholar] [CrossRef]
- Juniper, E.F.; Guyatt, G.H.; Cox, F.M.; Ferrie, P.J.; King, D.R. Development and Validation of the Mini Asthma Quality of Life Questionnaire. Eur. Respir. J. 1999, 14, 32–38. [Google Scholar] [CrossRef]
- Juniper, E.F.; Guyatt, G.H.; Epstein, R.S.; Ferrie, P.J.; Jaeschke, R.; Hiller, T.K. Evaluation of Impairment of Health Related Quality of Life in Asthma: Development of a Questionnaire for Use in Clinical Trials. Thorax 1992, 47, 76–83. [Google Scholar] [CrossRef]
- Juniper, E.F.; O’Byrne, P.M.; Guyatt, G.H.; Ferrie, P.J.; King, D.R. Development and Validation of a Questionnaire to Measure Asthma Control. Eur. Respir. J. 1999, 14, 902–907. [Google Scholar] [CrossRef] [PubMed]
- Quanjer, P.H.; Stanojevic, S.; Cole, T.J.; Baur, X.; Hall, G.L.; Culver, B.H.; Enright, P.L.; Hankinson, J.L.; Ip, M.S.M.; Zheng, J.; et al. Multi-Ethnic Reference Values for Spirometry for the 3-95-Yr Age Range: The Global Lung Function 2012 Equations. Eur. Respir. J. 2012, 40, 1324–1343. [Google Scholar] [CrossRef] [PubMed]
- Heffler, E.; Puggioni, F.; Peveri, S.; Montagni, M.; Canonica, G.W.; Melioli, G. Extended IgE Profile based on an Allergen Macroarray: A Novel Tool for Precision Medicine in Allergy Diagnosis. World Allergy Organ. J. 2018, 11, 7. [Google Scholar] [CrossRef] [PubMed]
- Goh, K.J.; Yii, A.C.A.; Lapperre, T.S.; Chan, A.K.W.; Chew, F.T.; Chotirmall, S.H.; Koh, M.S. Sensitization to Aspergillus Species Is Associated with Frequent Exacerbations in Severe Asthma. J. Asthma Allergy 2017, 10, 131–140. [Google Scholar] [CrossRef] [PubMed]
- Rojano, B.; West, E.; Ferdermann, E.; Markowitz, S.; Harrison, D.; Crowley, L.; Busse, P.; Federman, A.D.; Wisnivesky, J.P. Allergen Sensitization and Asthma Outcomes among World Trade Center Rescue and Recovery Workers. Int. J. Environ. Res. Public Health 2019, 16, 737. [Google Scholar] [CrossRef]
- Kleine-Tebbe, J.; Mailänder, C. Patterns of Allergen Sensitization in Patients with Severe Asthma in Germany. J. Allergy Clin. Immunol. Pract. 2020, 8, 744–746.e3. [Google Scholar] [CrossRef]
- Wps, S.I. ECAP Epidemiologia Chorób Alergicznych w Polsce. Available online: www.ecap.pl. (accessed on 30 June 2022).
- Hendrick, D.J.; Davies, R.J.; D’souza, M.F.; Pepys, J. An Analysis of Skin Prick Test Reactions in 656 Asthmatic Patients. Thorax 1975, 30, 2–8. [Google Scholar] [CrossRef]
- Leynaert, B.; Sunyer, J.; Garcia-Esteban, R.; Svanes, C.; Jarvis, D.; Cerveri, I.; Dratva, J.; Gislason, T.; Heinrich, J.; Janson, C.; et al. Gender Differences in Prevalence, Diagnosis and Incidence of Allergic and Non-Allergic Asthma: A Population-based Cohort. Thorax 2012, 67, 625. [Google Scholar] [CrossRef]
- Pakkasela, J.; Ilmarinen, P.; Honkamäki, J.; Tuomisto, L.E.; Andersén, H.; Piirilä, P.; Hisinger-Mölkänen, H.; Sovijärvi, A.; Backman, H.; Lundbäck, B.; et al. Age-Specific Incidence of Allergic and Non-Allergic Asthma. BMC Pulm. Med. 2020, 20, 9. [Google Scholar] [CrossRef]
- Takejima, P.; Agondi, R.C.; Rodrigues, H.; Aun, M.V.; Kalil, J.; Giavina-Bianchi, P. Allergic and Nonallergic Asthma Have Distinct Phenotypic and Genotypic Features. Int. Arch. Allergy Immunol. 2017, 172, 150–160. [Google Scholar] [CrossRef]
- Saarelainen, S.; Taivainen, A.; Rytkönen-Nissinen, M.; Auriola, S.; Immonen, A.; Mäntyjärvi, R.; Rautiainen, J.; Kinnunen, T.; Virtanen, T. Assessment of Recombinant Dog Allergens Can f 1 and Can f 2 for the Diagnosis of Dog Allergy. Clin. Exp. Allergy 2004, 34, 1576–1582. [Google Scholar] [CrossRef]
- Konradsen, J.R.; Nordlund, B.; Onell, A.; Borres, M.P.; Grönlund, H.; Hedlin, G. Severe Childhood Asthma and Allergy to Furry Animals: Refined Assessment Using Molecular-based Allergy Diagnostics. Pediatric Allergy Immunol. 2014, 25, 187–192. [Google Scholar] [CrossRef] [PubMed]
- Sposato, B.; Scalese, M.; Milanese, M.; Masieri, S.; Cavaliere, C.; Latorre, M.; Scichilone, N.; Matucci, A.; Vultaggio, A.; Ricci, A.; et al. Factors Reducing Omalizumab Response in Severe Asthma. Eur. J. Intern. Med. 2018, 52, 78–85. [Google Scholar] [CrossRef] [PubMed]
- Hon, K.L.; Tsang, K.Y.C.; Pong, N.H.H.; Leung, T.F. Relevance of Cat and Dog Sensitization by Skin Prick Testing in Childhood Eczema and Asthma. Curr. Pediatr. Rev. 2017, 13, 120–125. [Google Scholar] [CrossRef] [PubMed]
- Niedoszytko, M.; Chełmińska, M.; Jassem, E.; Czestochowska, E. Association between Sensitization to Aureobasidium Pullulans (Pullularia Sp) and Severity of Asthma. Ann. Allergy Asthma Immunol. 2007, 98, 153–156. [Google Scholar] [CrossRef]
- Wagner, G.E.; Gutfreund, S.; Fauland, K.; Keller, W.; Valenta, R.; Zangger, K. Backbone Resonance Assignment of Alt a 1, a Unique β-Barrel Protein and the Major Allergen of Alternaria Alternata. Biomol. NMR Assign. 2013, 8, 229–231. [Google Scholar] [CrossRef]
- Rajagopal, T.V.; Kant, S.; Verma, S.K.; Kushwaha, R.A.S.; Kumar, S.; Garg, R.; Srivastava, A.; Bajaj, D.K. Aspergillus Sensitization in Bronchial Asthma: A Separate Phenotype. Allergy Asthma Proc. 2020, 41, e26–e32. [Google Scholar] [CrossRef] [PubMed]
- Kleine-Tebbe, J.; Beyer, K.; Ebisawa, M. Molecular Allergology User’s Guide. Pediatr. Allergy Immunol. 2016, 27, 134–140. [Google Scholar]
- Twaroch, T.E.; Curin, M.; Sterflinger, K.; Focke-Tejkl, M.; Swoboda, I.; Valenta, R. Specific Antibodies for the Detection of Alternaria Allergens and the Identification of Cross-Reactive Antigens in Other Fungi. Int. Arch. Allergy Immunol. 2016, 170, 269–278. [Google Scholar] [CrossRef]
- Twaroch, T.E.; Curin, M.; Valenta, R.; Swoboda, I. Mold Allergens in Respiratory Allergy: From Structure to Therapy. Allergy Asthma. Immunol. Res. 2015, 7, 205–220. [Google Scholar] [CrossRef]
- Denning, D.W.; O’Driscoll, B.R.; Hogaboam, C.M.; Bowyer, P.; Niven, R.M. The Link between Fungi and Severe Asthma: A Summary of the Evidence. Eur. Respir. J. 2006, 27. [Google Scholar] [CrossRef]
- Masaki, K.; Fukunaga, K.; Matsusaka, M.; Kabata, H.; Tanosaki, T.; Mochimaru, T.; Kamatani, T.; Ohtsuka, K.; Baba, R.; Ueda, S.; et al. Characteristics of Severe Asthma with Fungal Sensitization. Ann. Allergy Asthma Immunol. 2017, 119, 253–257. [Google Scholar] [CrossRef] [PubMed]
- Zureik, M.; Neukirch, C.; Leynaert, B.; Liard, R.; Bousquet, J.; Neukirch, F. Sensitisation to Airborne Moulds and Severity of Asthma: Cross Sectional Study from European Community Respiratory Health Survey. Br. Med. J. 2002, 325, 411–414. [Google Scholar] [CrossRef] [PubMed]
- Nittner-Marszalska, M.; Liebhart, J.; Liebhart, E.; Dor, A.; Dobek, R.; Obojski, A.; Medrala, W. Prevalence of Hymenoptera Venom Allergy and Its Immunological Markers Current in Adults in Poland. Med. Sci. Monit. 2004, 10, CR324-9. [Google Scholar] [PubMed]
- Bartuzi, Z.; Bodzenta-Łukaszyk, A.; Kuna, P.; Kupryś-Lipińska, I.; Niżankowska-Mogilnicka, E.; Samoliński, B. The Statement of the Polish Society of Allergology Regarding Necessary Changes in Therapeutic Program of Severe IgE-Mediated Allergic Asthma with Omalizumab. Adv. Respir. Med. 2015, 83, 335–338. [Google Scholar] [CrossRef][Green Version]
Mean (Standard Deviation) | |
---|---|
Age | 50.4 (12.8) |
ACQ | 3.35 (1.14) |
MiniAQLQ | 3.41 (1.14) |
FEV1 (of expected values) | 66% (23%) |
VC (of expected valued) | 88% (20%) |
FEV1/VC (of expected values) | 71% (20%) |
Daily prednisone dose | 5.34 mg (7.7 mg) |
Total eosinophil count | 0.66 G/L (0.94 G/L) |
Total number of patients | 42 |
Average asthma duration in years | 18.33 (11.24) |
Number of inhaled sensitizations per patient | 1.42 (n/a) |
Number of patients with inhaled sensitizations pre study | 15 (n/a) |
Number of patients with inhaled sensitizations post study | 24 (n/a) |
Number of patients with detected new inhaled sensitizations | 9 (n/a) |
ACQ | MiniAQLQ | |||||||
---|---|---|---|---|---|---|---|---|
Allergen | p Value | Beta | Confidence Interval Range | p Value | Beta | Confidence Interval Range | ||
Phl p 1 | 0.323 | −0.158 | −0.478 | 0.162 | 0.888 | 0.023 | −0.301 | 0.346 |
Phl p 2 | 0.387 | −0.139 | −0.460 | 0.182 | 0.867 | 0.027 | −0.297 | 0.351 |
Phl p 5 | 0.363 | −0.146 | −0.466 | 0.175 | 0.861 | 0.028 | −0.295 | 0.352 |
Phl p 6 | 0.140 | −0.235 | −0.549 | 0.080 | 0.347 | 0.151 | −0.169 | 0.471 |
Bet v 1 | 0.318 | −0.160 | −0.480 | 0.160 | 0.691 | −0.064 | −0.387 | 0.259 |
Bet v 2 | 0.026 | −0.347 | −0.650 | −0.043 | 0.131 | 0.240 | −0.075 | 0.554 |
Bet v 6 | 0.359 | −0.147 | −0.467 | 0.173 | 0.442 | 0.123 | −0.198 | 0.445 |
Art v 1 | 0.286 | −0.171 | −0.490 | 0.149 | 0.643 | 0.075 | −0.248 | 0.398 |
Art v 3 | 0.761 | −0.049 | −0.373 | 0.274 | 0.656 | 0.072 | −0.251 | 0.395 |
Der f 1 | 0.560 | −0.094 | −0.416 | 0.229 | 0.936 | −0.013 | −0.337 | 0.311 |
Der f 2 | 0.342 | −0.152 | −0.472 | 0.168 | 0.890 | 0.022 | −0.302 | 0.346 |
Der p 1 | 0.489 | −0.111 | −0.433 | 0.211 | 0.821 | 0.036 | −0.287 | 0.360 |
Der p 2 | 0.335 | −0.154 | −0.474 | 0.166 | 0.874 | 0.026 | −0.298 | 0.349 |
Der p 5 | 0.792 | −0.043 | −0.366 | 0.281 | 0.829 | −0.035 | −0.358 | 0.289 |
Der p 7 | 0.157 | −0.225 | −0.541 | 0.090 | 0.444 | 0.123 | −0.199 | 0.444 |
Lep d 2 | 0.845 | −0.031 | −0.355 | 0.292 | 0.826 | −0.035 | −0.359 | 0.288 |
Tyr p 2 | 0.783 | −0.044 | −0.368 | 0.279 | 0.862 | −0.028 | −0.352 | 0.296 |
Alt a 1 | 0.056 | 0.301 | −0.008 | 0.610 | 0.591 | −0.086 | −0.409 | 0.236 |
Alt a 6 | 0.755 | 0.050 | −0.273 | 0.374 | 0.214 | −0.198 | −0.516 | 0.119 |
Asp f 1 | 0.470 | 0.116 | −0.206 | 0.438 | 0.384 | −0.140 | −0.460 | 0.181 |
Asp f 3 | 0.397 | −0.136 | −0.457 | 0.185 | 0.537 | 0.099 | −0.223 | 0.421 |
Asp f 4 | 0.253 | −0.183 | −0.501 | 0.136 | 0.534 | 0.100 | −0.222 | 0.422 |
Asp f 6 | 0.458 | 0.119 | −0.202 | 0.441 | 0.311 | 0.162 | −0.158 | 0.482 |
Can f 1 | 0.014 | 0.381 | 0.082 | 0.681 | 0.060 | −0.297 | −0.606 | 0.013 |
Can f 2 | 0.761 | −0.049 | −0.373 | 0.274 | 0.656 | 0.072 | −0.251 | 0.395 |
Can f 3 | 0.003 | −0.457 | −0.745 | −0.169 | 0.013 | 0.383 | 0.084 | 0.682 |
Can f 4 | 0.840 | −0.033 | −0.356 | 0.291 | 0.847 | −0.031 | −0.355 | 0.293 |
Can f 6 | 0.761 | −0.049 | −0.373 | 0.274 | 0.939 | −0.012 | −0.336 | 0.312 |
Fel d 1 | 0.965 | 0.007 | −0.317 | 0.331 | 0.372 | −0.143 | −0.464 | 0.177 |
Fel d 4 | 0.146 | −0.231 | −0.546 | 0.084 | 0.738 | 0.054 | −0.270 | 0.377 |
Fel d 7 | 0.320 | 0.159 | −0.161 | 0.479 | 0.218 | −0.197 | −0.514 | 0.121 |
FEV1 | VC | |||||||
---|---|---|---|---|---|---|---|---|
Allergen | p Value | Beta | Confidence Interval Range | p Value | Beta | Confidence Interval Range | ||
Phl p 1 | 0.018 | 0.367 | 0.066 | 0.668 | 0.076 | 0.280 | −0.030 | 0.591 |
Phl p 2 | 0.004 | 0.441 | 0.150 | 0.732 | 0.043 | 0.317 | 0.010 | 0.624 |
Phl p 5 | 0.001 | 0.507 | 0.228 | 0.786 | 0.005 | 0.432 | 0.140 | 0.724 |
Phl p 6 | 0.005 | 0.429 | 0.136 | 0.721 | 0.020 | 0.362 | 0.060 | 0.664 |
Bet v 1 | 0.355 | 0.148 | −0.172 | 0.469 | 0.435 | 0.125 | −0.196 | 0.447 |
Bet v 2 | 0.243 | 0.186 | −0.132 | 0.505 | 0.690 | 0.064 | −0.259 | 0.387 |
Bet v 6 | 0.302 | 0.165 | −0.154 | 0.485 | 0.986 | −0.003 | −0.327 | 0.321 |
Art v 1 | 0.127 | 0.242 | −0.072 | 0.557 | 0.217 | 0.197 | −0.121 | 0.514 |
Art v 3 | 0.875 | −0.025 | −0.349 | 0.299 | 0.467 | 0.117 | −0.205 | 0.438 |
Der f 1 | 0.527 | 0.102 | −0.220 | 0.424 | 0.339 | 0.153 | −0.167 | 0.473 |
Der f 2 | 0.093 | 0.266 | −0.046 | 0.578 | 0.334 | 0.155 | −0.165 | 0.475 |
Der p 1 | 0.481 | 0.113 | −0.209 | 0.435 | 0.294 | 0.168 | −0.151 | 0.487 |
Der p 2 | 0.091 | 0.268 | −0.044 | 0.580 | 0.318 | 0.160 | −0.160 | 0.480 |
Der p 5 | 0.589 | 0.087 | −0.236 | 0.410 | 0.433 | 0.126 | −0.196 | 0.447 |
Der p 7 | 0.049 | 0.309 | 0.001 | 0.617 | 0.166 | 0.220 | −0.095 | 0.536 |
Lep d 2 | 0.639 | 0.076 | −0.247 | 0.398 | 0.480 | 0.113 | −0.208 | 0.435 |
Tyr p 2 | 0.632 | 0.077 | −0.246 | 0.400 | 0.482 | 0.113 | −0.209 | 0.435 |
Alt a 1 | 0.951 | 0.010 | −0.314 | 0.334 | 0.763 | 0.048 | −0.275 | 0.372 |
Alt a 6 | 0.581 | −0.089 | −0.411 | 0.234 | 0.374 | 0.142 | −0.178 | 0.463 |
Asp f 1 | 0.056 | −0.301 | −0.610 | 0.008 | 0.542 | −0.098 | −0.420 | 0.224 |
Asp f 3 | 0.748 | 0.052 | −0.272 | 0.375 | 0.735 | 0.055 | −0.269 | 0.378 |
Asp f 4 | 0.803 | 0.040 | −0.284 | 0.364 | 0.750 | 0.051 | −0.272 | 0.375 |
Asp f 6 | 0.037 | −0.327 | −0.633 | −0.021 | 0.774 | −0.046 | −0.370 | 0.277 |
Can f 1 | 0.216 | −0.198 | −0.515 | 0.120 | 0.035 | −0.330 | −0.636 | −0.025 |
Can f 2 | 0.875 | −0.025 | −0.349 | 0.299 | 0.467 | 0.117 | −0.205 | 0.438 |
Can f 3 | 0.003 | 0.457 | 0.169 | 0.745 | 0.297 | 0.167 | −0.152 | 0.486 |
Can f 4 | 0.616 | 0.081 | −0.242 | 0.403 | 0.433 | 0.126 | −0.196 | 0.447 |
Can f 6 | 0.847 | 0.031 | −0.293 | 0.355 | 0.659 | −0.071 | −0.394 | 0.252 |
Fel d 1 | 0.540 | −0.099 | −0.421 | 0.224 | 0.234 | −0.190 | −0.508 | 0.128 |
Fel d 4 | 0.949 | 0.010 | −0.314 | 0.334 | 0.738 | −0.054 | −0.377 | 0.270 |
Fel d 7 | 0.252 | −0.183 | −0.501 | 0.135 | 0.063 | −0.293 | −0.603 | 0.017 |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Romantowski, J.; Górska, A.; Moszkowska, G.; Kulczycka, J.; Minkowska, K.; Rolewicz, A.; Nittner-Marszalska, M.; Niedoszytko, M. Atopy and Multisensitizations in Specific IgE Microarrays and Their Impact on Severe Asthma. Life 2022, 12, 1520. https://doi.org/10.3390/life12101520
Romantowski J, Górska A, Moszkowska G, Kulczycka J, Minkowska K, Rolewicz A, Nittner-Marszalska M, Niedoszytko M. Atopy and Multisensitizations in Specific IgE Microarrays and Their Impact on Severe Asthma. Life. 2022; 12(10):1520. https://doi.org/10.3390/life12101520
Chicago/Turabian StyleRomantowski, Jan, Aleksandra Górska, Grażyna Moszkowska, Julia Kulczycka, Karolina Minkowska, Agata Rolewicz, Marita Nittner-Marszalska, and Marek Niedoszytko. 2022. "Atopy and Multisensitizations in Specific IgE Microarrays and Their Impact on Severe Asthma" Life 12, no. 10: 1520. https://doi.org/10.3390/life12101520
APA StyleRomantowski, J., Górska, A., Moszkowska, G., Kulczycka, J., Minkowska, K., Rolewicz, A., Nittner-Marszalska, M., & Niedoszytko, M. (2022). Atopy and Multisensitizations in Specific IgE Microarrays and Their Impact on Severe Asthma. Life, 12(10), 1520. https://doi.org/10.3390/life12101520